Biosynthetic Technologies acquires Innoleo

Biosynthetic Technologies acquires Innoleo

Biosynthetic® Technologies, LLC has acquired Innoleo®, LLC, a privately-held distributor of castor derivatives for grease, lubricants, metalworking fluids, coatings and personal care applications. The Ohio based company has over 75 years of experience in the chemical industry with these  renewable bio-based oleo derivatives.

Biosynthetic Technologies markets a new class of high-performance bio-based products based on its proprietary estolide technology, to formulate lubricants and metalworking fluids. These estolides are bio-based, biodegradable, non-bioaccumulative, and non-toxic.

The acquisition will enable Biosynthetic Technologies, based in Indianapolis, Indiana, U.S.A., to add a comprehensive line of castor and other oleo derivatives to its existing Estolide technology portfolio. 

“Meeting our focus of innovations for a sustainable future, our new line of  commodity castor derivatives will create the perfect addition to our current Estolide product line. All products are highly suitable for the manufacture of environmentally acceptable lubricants (EAL) formulations,” said Dr. Matthew Kriech, COO of Biosynthetic Technologies and the new CEO of Innoleo, LLC.

The following products will be available globally from Biosynthetic Technologies effective immediately:

  • Castor oil
  • Neutralized castor oil
  • Pale pressed castor oil
  • Castor oil, USP grade
  • Hydrogenated castor oil
  • 12HSA 12-hydroxy stearic acid
  • Stearic acid, 70%
  • Methyl 12-hydroxy stearate
  • n,n ethylene bis 12-hydroxy Stearamide
  • Sebacic Acid
  • Dimethyl Sebacate
  • Dibutyl Sebacate
  • Ricinoleic Acid
  • Sodium Ricinoleate
  • Methyl Ricinoleate

“We are incredibly excited about this recent agreement with Biosynthetic Technologies, as this organization truly shares our goals and values for a sustainable future. The combined efforts of these companies, will enable us to reach even more customers around the world with our growing portfolio of renewable castor and other oleo derivatives, utilizing the broad network and geographic footprint of Biosynthetic Technologies,” said Adele Savaiano, COO of Innoleo, LLC.

“These products are an excellent product line extension to BT’s high-performance Estolides and specialty oleo derivatives. We now can offer the industry a full assortment of oleo products from very specialized to commodity,”  said Mark Miller, CEO at Biosynthetic Technologies.  “The unique structure of castor oil offers interesting properties, making it appropriate for various industrial applications. Castor oil is valuable due to the high content of ricinoleic acid (RA), which is used in a variety of applications in the chemical, personal care and lubricant industries and provides a sustainable drop in replacement for many applications.”